U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ADEGRAPEPIMUT-S
4XQ7W02EQ0
Investigational
General
Names
9
Classification
2
Identifiers
9
Subunits
1
Related Substances
1
ADEGRAPEPIMUT-S
4XQ7W02EQ0
Investigational
General
Approval Year
Unknown
149,124
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ADEGRAMOTIDE
Preferred Name
English
ADEGRAPEPIMUT-S
Official Name
English
L-LEUCINE, L-TRYPTOPHYL-L-ALANYL-L-PROLYL-L-VALYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-PHENYLALANYL-L-ALANYL-L-PROLYL-L-PROLYLGLYCYL-L-ALANYL-L-SERYL-L-ALANYL-L-TYROSYLGLYCYL-L-SERYL-
Systematic Name
English
DSR-131617
Code
English
adegramotide [INN]
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of myelodysplastic syndrome.
FDA ORPHAN DRUG
571516
Designated
ORPHAN DRUG
Designated
Treatment of brain cancer
FDA ORPHAN DRUG
603617
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
9
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
WIKIPEDIA
Adegramotide
PRIMARY
NCI_THESAURUS
C171727
PRIMARY
PUBCHEM
121488164
PRIMARY
USAN
EF-93
PRIMARY
INN
10324
PRIMARY
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Subunits
1
Related Substances
1
ACTIVE MOIETY
4XQ7W02EQ0
ADEGRAPEPIMUT-S
